feed,title,long_url,short_url
Benzinga,EXCLUSIVE: Alzamend Neuro Completes Clinical Portion Of Mid-Stage Alzheimer's Trial,https://benzinga.com/general/biotech/23/03/31453047/exclusive-alzamend-neuro-completes-clinical-portion-of-mid-stage-alzheimers-trial,https://da.gd/pP88aq
Benzinga,"Buy Nvidia Stock, Says Analyst, Following GTC Keynote: Chipmaker In 'Unique Position' To 'Best Monetize AI Across All Fronts'",https://benzinga.com/analyst-ratings/analyst-color/23/03/31452830/buy-nvidia-stock-says-analyst-following-gtc-keynote-chipmaker-in-unique-position-to,https://da.gd/sJUHl
